Pregledni rad

SECONDARY (AA) AMYLOIDOSIS IN CROHN’S DISEASE

TOMISLAV BULUM ; Sveučilišna klinika za dijabetes, endokrinologiju i bolesti metabolizma Vuk Vrhovac, Zagreb, Hrvatska
INGRID PRKAČIN ; Klinika za unutarnje bolesti, Klinčka bolnica Merkur, Zagreb, Hrvatska
GORDANA CAVRIĆ ; Klinika za unutarnje bolesti, Klinčka bolnica Merkur, Zagreb, Hrvatska
NIKOLA SOBOČAN ; Klinika za unutarnje bolesti, Klinčka bolnica Merkur, Zagreb, Hrvatska
BRUNO ŠKURLA ; Klinika za unutarnje bolesti, Klinčka bolnica Merkur, Zagreb, Hrvatska
LEA DUVNJAK ; Sveučilišna klinika za dijabetes, endokrinologiju i bolesti metabolizma Vuk Vrhovac, Zagreb, Hrvatska
STELA BULIMBAŠIĆ ; Zavod za patologiju, Klinička bolnica Dubrava, Zagreb, Hrvatska

Sažetak

Amyloidosis is a clinical entity that results from deposition of an extracellular protein material that causes disruption in normal architecture and impairs function of multiple organs and tissues. Secondary amyloidosis (AA) is a rare but serious complication that occurs in the context of cancer, chronic inflammation and chronic infectious diseases, including inflammatory bowel disease, mainly long-standing Crohn’s disease. Renal failure is the most common clinical presentation of AA, ranging from nephrotic syndrome and impaired renal function to renal failure, with a potential for high morbidity. The incidence of the association of t. Bulum, i. Prka

Ključne riječi

amyloidosis; Crohn’s disease; nephrotic syndrome

Hrčak ID:

89275

URI

https://hrcak.srce.hr/89275

Datum izdavanja:

17.10.2012.

Podaci na drugim jezicima: hrvatski

Posjeta: 3.097 *